C-reactive protein-albumin-lymphocyte index and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis
The C-reactive protein-albumin-lymphocyte (CALLY) index is a composite biomarker integrating systemic inflammation, nutritional status, and immune competence. Although its prognostic value has been investigated in several malignancies, its clinical relevance in renal cell carcinoma (RCC) remains incompletely define...